Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Patient self-testing  





2 Patient self-management  





3 International Normalized Ratio (INR)  





4 The advantages of self-monitoring  





5 UK NHS on self-monitoring  





6 Who self-monitoring is suitable for  





7 Clinical trials  



7.1  Clinical reports about INR self-monitoring  







8 Monitors  





9 See also  





10 References  





11 External links  














INR self-monitoring






Deutsch
Nederlands
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


INR self-monitoring
Purposeself measure their INR (due to anti-coagulation therapy)

INR self-monitoring is a medical kit that is used by patients both on long-term and on lifetime anti-coagulation therapy to measure their INR (International Normalized Ratio) levels themselves at your premises without going to

a clinic. People who self-monitor their INR levels use a portable INR monitor as in a clinic. It requires the patient to test a drop of blood, drawn from a finger at scheduled times, and record the INR level measured by a monitor.

Patient self-testing

[edit]
INR self monitoring with one blood drop. the INR is too high and the warfarine dose must be decreased.

People on anti-coagulation therapy who are self-testing provide the INR upi antem76102824@axl reading they obtain from their monitor to their healthcare professionals at an agreed time, generally by telephone. The healthcare professional decides if any change to the warfarin dose is required and lets the person know what action is needed. A PT/INR meter can be obtained by contacting an Independent Diagnostic Testing Facility (IDTF).[1] They are able to provide patients with all necessary testing equipment and bill the insurance for test results reported.[citation needed]

Patient self-management

[edit]

People who self-manage adjust their warfarin doses themselves, following training with their healthcare professional. This means that if the INR reading obtained from their monitor is out of the normal therapeutic range, they are able to make an adjustment to their own warfarin dose by themselves.[citation needed]

International Normalized Ratio (INR)

[edit]

International normalized ratio (INR) which is a derivative of prothrombin time is a measurement of blood coagulation in the circulatory system. Both are used to determine the clotting rate of blood, which can be affected by anticoagulant usage, liver damage and Vitamin K levels. The preferred range of INR levels for a patient on anticoagulation therapy is usually between 2 and 3, but it tends to vary depending on the patient's requirements.[2]

The advantages of self-monitoring

[edit]

Patients who self-monitor tend to choose this route for the greater control they feel it gives them over their lives and their condition. This helps to reduce the number of visits being made to their anticoagulation clinic for routine appointments to measure their INR levels. This is a lengthy process in comparison to self-testing and management. Results of clinical studies, which have been recognized by the National Patients Safety Authority (NPSA), show that people who self-monitor keep more frequently within their therapeutic range and have fewer complications including clots and bleeding, compared with people who have their INR levels tested only at their anticoagulation clinic.[citation needed]

UK NHS on self-monitoring

[edit]

Patient self-care is a key initiative in the NHS Plan for a patient-centered health service and an important component in supporting people with long-term conditions.[3] It is seen to provide:

Who self-monitoring is suitable for

[edit]

Self-monitoring may be a suitable option for a variety of people who are on long term anticoagulation therapy and want the convenience of being able to monitor their own INR levels at a time and place of their own choosing (e.g. if travelling abroad either with work or on vacation). They do have continuous support from their healthcare professionals and there are no upper age limits for self-monitoring and parents can take charge for their children. Self-monitoring is ideal if:[citation needed]

Clinical trials

[edit]

In the past 5 years, there have been a number of clinical trials to highlight the advantages of self-monitoring, whether self-testing or self-managing. It also gives an indication of what improvements the self-testing and self-management can do to INR levels.[citation needed]

Clinical reports about INR self-monitoring

[edit]

"Quality of life changed in a positive way. Independence and better organisation of vacation and spare time were most frequently mentioned advantages."

Extract from a study into the impact of self-monitoring on the quality of life of patients under anticoagulation therapy.[6]

"Patient self-testing . . . is an effective method of monitoring oral anticoagulation therapy, providing outcomes at least as good as, and possibly better than, those achieved with an anti-coagulation clinic."

From international consensus guidelines prepared by the International Self-Monitoring Association for Oral Anti-coagulation.[7]

"Self-monitoring can improve the quality of oral anti-coagulation therapy, with patients more frequently in the therapeutic range, while improving benefits and decreasing harm."

From the conclusions of a review of studies of self-monitoring in oral anti-coagulation therapy.[8][9]

The results of the study Effect of Home Testing of International Normalized Ratio on Clinical Events (2010), comparing whether weekly home-testing of the INR-level offers any advantage over monthly testing in a clinic, reduces the risk of a major hemorrhage event (i.e. stroke, major bleeding, or death), indicated that the time to the first primary-event (stroke, major bleeding, or death) was not significantly longer in the self-testing group of patients than in the clinic-testing group of patients (hazard ratio, 0.88; 95% confidence interval, 0.75 to 1.04; p=0.14). The study was a prospective, randomized, non-blinded trial for which the patients were randomized into two groups, (i) weekly INR self-testing and (ii) monthly INR clinic-testing, using a stratified method of adaptive-allocation that was determined according to the duration of anti-coagulation and the indication for Warfarin. Although the study was non-blinded, blinding is less critical because the objective outcomes of the study: stroke, major bleeding episode, and death.[10]

Monitors

[edit]

Patients who are self-monitoring have to use a monitor in order to measure their INR level. There are a range of INR testing monitors on the market, such as the CoaguChek XS,[11][12] MicroINR.,[13] INRatio2,[14] and QLabs[15]

See also

[edit]

References

[edit]
  1. ^ "PT/INR Home Testing Service | How our Service Works". Archived from the original on 2014-03-03. Retrieved 2014-02-27.
  • ^ "International Normalized Ratio - Health Encyclopedia - University of Rochester Medical Center". www.urmc.rochester.edu. Retrieved 2022-10-27.
  • ^ "Self care - A real choice: Self care support - A practical option : Department of Health - Publications and statistics". www.dh.gov.uk. Archived from the original on 2007-03-23.
  • ^ Kulinna, W., Ney, D., Wenzel, T., Heene, D., & Harenberg, J. (1999). The Effect of Self-Monitoring the INR on Quality of Anticoagulation and Quality of Life. Seminars in Thrombosis and Hemostasis, 25(01), 123–126. doi:10.1055/s-2007-996435
  • ^ Gadisseur APA et al. Ann Intern Med 2004:2:584-91
  • ^ Kulinna, W., Ney, D., Wenzel, T., Heene, D., & Harenberg, J. (1999). The Effect of Self-Monitoring the INR on Quality of Anticoagulation and Quality of Life. Seminars in Thrombosis and Hemostasis, 25(01), 123–126. doi:10.1055/s-2007-996435
  • ^ Ansell J. et al. International Journal of Cardiology 2005:99:37-45
  • ^ Heneghan, Carl, et al. "Self-monitoring of oral anticoagulation: a systematic review and meta-analysis." The Lancet 367.9508 (2006): 404-411.
  • ^ http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD003839/frame.html
  • ^ Matchar,D.B. (2010)"Effect of home testing of international normalized ratio on clinical events."
  • ^ "CoaguChek XS PT Test Strips".
  • ^ "Home | Discover INR self-testing with CoaguChek from Roche".
  • ^ "ILine microsystems". Archived from the original on 2019-04-17. Retrieved 2011-11-06.
  • ^ "Alere INRatio PT/INR Monitoring System - Home". www.alereinratio.pl. Archived from the original on 2011-02-21.
  • ^ "QLabs Q1 model 2019 PL – RedMed".
  • [edit]
    Retrieved from "https://en.wikipedia.org/w/index.php?title=INR_self-monitoring&oldid=1229009538"

    Categories: 
    Blood tests
    Medical monitoring
    Hidden categories: 
    Articles with a promotional tone from June 2019
    All articles with a promotional tone
    Articles needing cleanup from August 2022
    Articles with bare URLs for citations from August 2022
    All articles with bare URLs for citations
    Articles covered by WikiProject Wikify from August 2022
    All articles covered by WikiProject Wikify
    All articles with unsourced statements
    Articles with unsourced statements from July 2020
    Articles with unsourced statements from April 2022
     



    This page was last edited on 14 June 2024, at 10:16 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki